Torii Pharmaceutical Co Ltd
TSE:4551
Torii Pharmaceutical Co Ltd
TSE:4551
Price:
6 330
JPY
Market Closed
Market Cap:
¥182.3B
Balance Sheet
Balance Sheet Decomposition
Torii Pharmaceutical Co Ltd
Torii Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Torii Pharmaceutical Co Ltd
Torii Pharmaceutical Co Ltd
Balance Sheet
Torii Pharmaceutical Co Ltd
Torii Pharmaceutical Co Ltd
Currency: JPY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
6 316
|
14 361
|
22 393
|
6 458
|
3 484
|
5 773
|
3 717
|
4 012
|
9 203
|
5 004
|
3 319
|
|
| Cash Equivalents |
6 316
|
14 361
|
22 393
|
6 458
|
3 484
|
5 773
|
3 717
|
4 012
|
9 203
|
5 004
|
3 319
|
|
| Short-Term Investments |
13 209
|
18 708
|
11 102
|
24 957
|
28 606
|
33 150
|
38 528
|
38 198
|
38 489
|
38 999
|
39 979
|
|
| Total Receivables |
25 901
|
27 904
|
26 560
|
29 122
|
27 137
|
25 150
|
18 955
|
22 010
|
22 865
|
28 502
|
31 068
|
|
| Accounts Receivables |
25 894
|
27 897
|
26 553
|
29 108
|
27 137
|
25 136
|
18 948
|
22 010
|
22 865
|
28 488
|
31 061
|
|
| Other Receivables |
7
|
7
|
7
|
14
|
0
|
14
|
7
|
0
|
0
|
14
|
7
|
|
| Inventory |
10 135
|
9 835
|
10 606
|
10 125
|
8 313
|
7 513
|
7 151
|
8 763
|
8 969
|
10 742
|
14 217
|
|
| Other Current Assets |
16 560
|
6 347
|
9 462
|
13 318
|
10 913
|
38 431
|
28 391
|
24 309
|
12 077
|
4 901
|
6 057
|
|
| Total Current Assets |
72 121
|
77 155
|
80 123
|
83 980
|
78 453
|
110 017
|
96 742
|
97 292
|
91 603
|
88 148
|
94 640
|
|
| PP&E Net |
5 806
|
6 182
|
5 752
|
5 540
|
3 431
|
2 778
|
1 777
|
2 078
|
2 282
|
2 095
|
2 451
|
|
| PP&E Gross |
5 806
|
6 182
|
5 752
|
5 540
|
3 431
|
2 778
|
1 777
|
2 078
|
2 282
|
2 095
|
2 451
|
|
| Accumulated Depreciation |
18 010
|
18 245
|
18 959
|
19 541
|
19 592
|
19 295
|
4 263
|
4 343
|
4 591
|
4 851
|
5 020
|
|
| Intangible Assets |
818
|
955
|
896
|
817
|
669
|
526
|
442
|
512
|
517
|
429
|
321
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
7 070
|
6 800
|
3 877
|
7 478
|
13 770
|
19 764
|
20 810
|
22 309
|
30 282
|
33 970
|
33 197
|
|
| Other Long-Term Assets |
6 734
|
7 776
|
7 877
|
6 926
|
6 930
|
6 858
|
6 255
|
8 619
|
9 005
|
8 790
|
10 055
|
|
| Total Assets |
92 550
N/A
|
98 868
+7%
|
98 525
0%
|
104 741
+6%
|
103 253
-1%
|
139 943
+36%
|
126 026
-10%
|
130 810
+4%
|
133 689
+2%
|
133 432
0%
|
140 664
+5%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
6 095
|
6 853
|
6 698
|
8 242
|
6 657
|
5 752
|
5 143
|
5 793
|
6 584
|
6 981
|
10 448
|
|
| Accrued Liabilities |
1 773
|
1 370
|
1 376
|
1 482
|
1 495
|
828
|
689
|
812
|
753
|
931
|
967
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
331
|
342
|
199
|
85
|
85
|
85
|
85
|
211
|
283
|
222
|
148
|
|
| Other Current Liabilities |
3 192
|
5 907
|
5 037
|
6 059
|
6 037
|
18 277
|
3 544
|
5 556
|
5 601
|
4 370
|
6 590
|
|
| Total Current Liabilities |
11 391
|
14 472
|
13 310
|
15 868
|
14 274
|
24 942
|
9 461
|
12 372
|
13 221
|
12 504
|
18 153
|
|
| Long-Term Debt |
387
|
725
|
571
|
465
|
380
|
294
|
209
|
275
|
241
|
22
|
281
|
|
| Other Liabilities |
547
|
845
|
1 088
|
1 289
|
1 507
|
1 582
|
1 265
|
1 148
|
1 003
|
772
|
697
|
|
| Total Liabilities |
12 325
N/A
|
16 042
+30%
|
14 969
-7%
|
17 622
+18%
|
16 161
-8%
|
26 818
+66%
|
10 935
-59%
|
13 795
+26%
|
14 465
+5%
|
13 298
-8%
|
19 131
+44%
|
|
| Equity | ||||||||||||
| Common Stock |
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
|
| Retained Earnings |
69 102
|
71 384
|
72 870
|
76 247
|
76 067
|
102 087
|
104 234
|
106 250
|
108 846
|
109 425
|
110 813
|
|
| Additional Paid In Capital |
6 416
|
6 416
|
6 416
|
6 416
|
6 426
|
6 429
|
6 437
|
6 445
|
6 453
|
6 460
|
6 473
|
|
| Unrealized Security Profit/Loss |
377
|
698
|
558
|
745
|
864
|
850
|
636
|
523
|
117
|
427
|
414
|
|
| Treasury Stock |
861
|
863
|
1 478
|
1 480
|
1 455
|
1 431
|
1 407
|
1 393
|
1 381
|
1 369
|
1 358
|
|
| Other Equity |
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
| Total Equity |
80 225
N/A
|
82 826
+3%
|
83 556
+1%
|
87 119
+4%
|
87 092
0%
|
113 125
+30%
|
115 091
+2%
|
117 015
+2%
|
119 224
+2%
|
120 134
+1%
|
121 533
+1%
|
|
| Total Liabilities & Equity |
92 550
N/A
|
98 868
+7%
|
98 525
0%
|
104 741
+6%
|
103 253
-1%
|
139 943
+36%
|
126 026
-10%
|
130 810
+4%
|
133 689
+2%
|
133 432
0%
|
140 664
+5%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
|
Switch to:
Switch to:
See Also
Discover More
